Daniel Gilbert on Muck Rack

Daniel Gilbert

Verified
  • Investigative Reporter, CBS News
  • None, Washington Post, The
  • None, Washington Post
Washington, D.C.
As seen in: CBS News, MSN, MSN Canada, MSN Ireland, UOL, Yahoo Life, The Washington Post, Yahoo Canada, Yahoo News, Yahoo News Malaysia, Yahoo News New Zealand and
Investigations @CBSNews, ex-@washingtonpost @wsj. Pulitzer winner. Signal: bydanielgilbert.08
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Daniel

Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

What a Brooklyn bodega reveals about the craze for an experimental weight-loss drug Original

|
By Daniel Gilbert Verified, Adam Yamaguchi Verified, Laura Geller Verified
| CBS News Verified
Behind the counter of a bodega in Brooklyn, a cashier casually rang up a tiny vial of a peptide the store advertised as retatrutide — an experimental weight-loss drug whose sale is generally prohibited by federal law. "PEPTIDES SOLD HERE" reads a large sign displayed on the storefront of Mr. Green, a small shop on a busy stretch of Bedford Avenue sandwiched between a poke restaurant and a funeral home.
Open in Who Shared View Duplicates (5) Issue with article?

How an experimental weight-loss drug is being openly promoted by physicians

|
By Daniel Gilbert Verified
| Aol Verified
Updated Mon, June 8, 2026 at 10:31 AM UTC How an experimental weight-loss drug is being openly promoted by physicians Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Drug Administration hasn't reviewed whether it is safe and effective, which is the legal path for prescription drugs to come to market.
Open in Who Shared Issue with article?

How an experimental weight-loss drug is being openly promoted by physicians

|
By Daniel Gilbert Verified
| Yahoo Verified
Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Drug Administration hasn't reviewed whether it is safe and effective, which is the legal path for prescription drugs to come to market. And yet retatrutide is for sale all over the internet, a phenomenon with no modern precedent.
Open in Who Shared Issue with article?
See all 888 licensed articles (946 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified